Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both

Paul E Pfeffer, Nasloon Ali, Ruth Murray, Charlotte Ulrik, Trung N Tran, Jorge Maspero, Matthew Peters, George C Christoff, Mohsen Sadatsafavi, Carlos A Torres-Duque, Alan Altraja, Lauri Lehtimäki, Nikolaos G Papadopoulos, Sundeep Salvi, Richard W Costello, Breda Cushen, Enrico Heffler, Takashi Iwanaga, Mona Al-Ahmad, Désirée Larenas-LinnemannPiotr Kuna, João A Fonseca, Riyad Al-Lehebi, Chin Kook Rhee, Luis Perez-de-Llano, Diahn-Warng Perng Steve, Bassam Mahboub, Eileen Wang, Celine Goh, Juntao Lyu, Anthony Newell, Marianna Alacqua, Andrey S Belevskiy, Mohit Bhutani, Leif Bjermer, Unnur Bjornsdottir, Arnaud Bourdin, Anna von Bulow, John Busby, Giorgio Walter Canonica, Borja G Cosio, Del Dorscheid, Mariana Muñoz-Esquerre, J Mark FitzGerald, Esther Garcia Gil, Peter G Gibson, Liam G Heaney, Mark Hew, Ole Hilberg, Flavia Hoyte, David J Jackson, Mariko Siyue Koh, Hsin-Kuo Ko Bruce, Jae Ha Lee, Sverre Lehmann, Cláudia Chaves Loureiro, Dóra Lúðvíksdóttir, Andrew N Menzies-Gow, Patrick Mitchell, Andriana I Papaioannou, Todor A Popov, Celeste M Porsbjerg, Laila Salameh, Concetta Sirena, Camille Taillé, Christian Taube, Yuji Tohda, Michael E Wechsler, David Price

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science